1
|
Aouad K, de Wit M, Elhai M, Benavent D, Bertheussen H, Zabalan C, Primdahl J, Studenic P, Gossec L. Patient research partner involvement in rheumatology research: a systematic literature review informing the 2023 updated EULAR recommendations for the involvement of patient research partners. Ann Rheum Dis 2024; 83:1268-1277. [PMID: 38724076 DOI: 10.1136/ard-2024-225567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Accepted: 04/28/2024] [Indexed: 10/02/2024]
Abstract
BACKGROUND Patient research partners (PRPs) are people with a disease who collaborate in a research team as partners. The aim of this systematic literature review (SLR) was to assess barriers and facilitators to PRP involvement in rheumatology research. METHODS The SLR was conducted in PubMed/Medline for articles on PRP involvement in rheumatology research, published between 2017 and 2023; websites were also searched in rheumatology and other specialties. Data were extracted regarding the definition of PRPs, their role and added value, as well as barriers and facilitators to PRP involvement. The quality of the articles was assessed. Quantitative data were analysed descriptively, and principles of thematic content analysis was applied to qualitative data. RESULTS Of 1016 publications, 53 articles were included; the majority of these studies were qualitative studies (26%), opinion articles (21%), meeting reports (17%) and mixed-methods studies (11%). Roles of PRPs ranged from research partners to patient advocates, advisors and patient reviewers. PRPs were reported/advised to be involved early in the project (32% of articles) and in all research phases (30%), from the conception stage to the implementation of research findings. The main barriers were challenges in communication and support for both PRPs and researchers. Facilitators of PRP involvement included more than one PRP per project, training of PRPs and researchers, a supportive environment for PRPs (including adequate communication, acknowledgement and compensation of PRPs) and the presence of a PRP coordinator. CONCLUSION This SLR identified barriers and facilitators to PRP involvement, and was key to updating the European Alliance of Associations for Rheumatology recommendations for PRP-researcher collaboration based on scientific evidence.
Collapse
Affiliation(s)
- Krystel Aouad
- Rheumatology Division, Saint George University of Beirut, Saint George Hospital University Medical Center, Beirut, Lebanon
| | - Maarten de Wit
- EULAR Study Group for collaborative research, Patient Research Partner, Amsterdam, The Netherlands
| | - Muriel Elhai
- Rheumatology Department, University of Zurich, University Hospital Zurich, Zurich, Switzerland
| | - Diego Benavent
- Rheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain
| | | | | | - Jette Primdahl
- Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark
| | - Paul Studenic
- Rheumatology Division, Department of Medicine(Solna), Karolinska Institutet, Stockholm, Sweden
- Rheumatology Division, Internal Medicine Department, Medical University of Vienna, Vienna, Austria
| | - Laure Gossec
- Rheumatology Department, University Hospital Pitié Salpêtrière, Paris, France
- INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France
| |
Collapse
|
2
|
de Wit M, Aouad K, Elhai M, Benavent D, Bertheussen H, Blackburn S, Böhm P, Duarte C, Falahee M, Karlfeldt S, Kiltz U, Mateus EF, Richards DP, Rodríguez-Carrio J, Sagen J, Shumnalieva R, Stones SR, Tas SW, Tillett W, Vieira A, Wilhelmer TC, Zabalan C, Primdahl J, Studenic P, Gossec L. EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update. Ann Rheum Dis 2024:ard-2024-225566. [PMID: 38876509 DOI: 10.1136/ard-2024-225566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Accepted: 05/22/2024] [Indexed: 06/16/2024]
Abstract
BACKGROUND Since the publication of the 2011 European Alliance of Associations for Rheumatology (EULAR) recommendations for patient research partner (PRP) involvement in rheumatology research, the role of PRPs has evolved considerably. Therefore, an update of the 2011 recommendations was deemed necessary. METHODS In accordance with the EULAR Standardised Operational Procedures, a task force comprising 13 researchers, 2 health professionals and 10 PRPs was convened. The process included an online task force meeting, a systematic literature review and an in-person second task force meeting to formulate overarching principles (OAPs) and recommendations. The level of agreement of task force members was assessed anonymously (0-10 scale). RESULTS The task force developed five new OAPs, updated seven existing recommendations and formulated three new recommendations. The OAPs address the definition of a PRP, the contribution of PRPs, the role of informal caregivers, the added value of PRPs and the importance of trust and communication in collaborative research efforts. The recommendations address the research type and phases of PRP involvement, the recommended number of PRPs per project, the support necessary for PRPs, training of PRPs and acknowledgement of PRP contributions. New recommendations concern the benefits of support and guidance for researchers, the need for regular evaluation of the patient-researcher collaboration and the role of a designated coordinator to facilitate collaboration. Agreements within the task force were high and ranged between 9.16 and 9.96. CONCLUSION The updated EULAR recommendations for PRP involvement are more substantially based on evidence. Together with added OAPs, they should serve as a guide for researchers and PRPs and will ultimately strengthen the involvement of PRPs in rheumatology research.
Collapse
Affiliation(s)
- Maarten de Wit
- Patient Research Partner, EULAR, Amsterdam, The Netherlands
| | - Krystel Aouad
- Saint George Hospital University Medical Center, Beirut, Lebanon
| | - Muriel Elhai
- University Hospital Zürich, University of Zürich, Zürich, Switzerland
| | - Diego Benavent
- Rheumatology, Hospital Universitari de Bellvitge, Madrid, Spain
| | | | - Steven Blackburn
- Institute of Applied Health Research, Univeristy of Birmingham, Birmingham, UK
| | - Peter Böhm
- Patient Research Partner, EULAR, Berlin, Germany
| | - Catia Duarte
- Rheumatology, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal
| | - Marie Falahee
- Institute of Inflammation and Ageing, University of Birmingham Rheumatology Research Group, Birmingham, UK
| | - Susanne Karlfeldt
- Academic Specialist Center, Karolinska Institutet, Stockholm, Sweden
| | - Uta Kiltz
- Ruhr University Bochum, Bochum, Germany
- Rheumazentrum Ruhrgebiet, Herne, Germany
| | - Elsa F Mateus
- Patient Research Partner, EULAR, Lisbon, Portugal
- Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal
| | - Dawn P Richards
- Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada
| | - Javier Rodríguez-Carrio
- Area of Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), University of Oviedo, Oviedo, Spain
| | - Joachim Sagen
- Norwegian National Advisory Unit on Rehabilitation in Rheumatology, Oslo, Norway
- Norwegian Rheumatism Association, Oslo, Norway
| | - Russka Shumnalieva
- Department of Rheumatology, Clinic of Rheumatology, University Hospital "St Ivan Rilski", Medical University-Sofia, Sofia, Bulgaria
| | - Simon R Stones
- Patient Research Partner, EULAR, Manchester, UK
- Envision Pharma Group, Wilmslow, UK
| | - Sander W Tas
- Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centres, Amsterdam, The Netherlands
| | - William Tillett
- Royal National Hospital for Rheumatic Disease, Bath, UK
- Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, UK
| | - Ana Vieira
- Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal
- Patient Research Partner, EULAR, Lissabon, Portugal
| | - Tanita-Christina Wilhelmer
- EULAR Young PARE, Zürich, Switzerland
- Österreichische Rheumaliga, Maria Alm, Austria
- EULAR PRP, Vienna, Austria
| | - Condruta Zabalan
- Romanian League Against Rheumatism, Bucharest, Romania
- EULAR PRP, Bucharest, Romania
| | - Jette Primdahl
- Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark
- Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
| | - Paul Studenic
- Internal Medicine 3, Division of Rheumatology, Medical University Vienna, Vienna, Austria
- Department of Medicine (Solna), Karolinska Institutet, Division of Rheumatology, Stockholm, Sweden
| | - Laure Gossec
- INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France
- APHP, Rheumatology Department, Hopital Universitaire Pitie Salpetriere, Paris, France
| |
Collapse
|
3
|
Schöpf-Lazzarino AC, Böhm P, Garske U, Schlöffel M, Stoye A, Lamprecht J, Mau W, Farin E. Involving patients as research partners exemplified by the development and evaluation of a communication-skills training programme (KOKOS-Rheuma). Z Rheumatol 2021; 80:132-139. [PMID: 32676754 PMCID: PMC7929963 DOI: 10.1007/s00393-020-00839-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Despite widespread recommendations for involving patient research partners (PRPs), there is little information about how patients have been involved in research. Our aim was to describe and assess the contributions of four PRPs in a project on communication-skills training funded by Deutsche Rheuma-Liga Bundesverband e. V. (German League Against Rheumatism [GLR] is a patient organisation for people with rheumatic and musculoskeletal diseases). The PRPs' participation was beneficial with regards to content and organisation. Thanks to their participation, we could enlarge our sample by over a third, and they contributed their own ideas to the training. Four PRPs added their perspective of various regional organisations. Outside this project, they were also very active within GLR and experienced in managing their rheumatic disease. To achieve more representativeness, future studies might also employ strategies to engage individuals with less experience in dealing with their disease, e.g. newly diagnosed patients. While the collaboration between PRPs and researchers proved very successful, more regular discussions about tasks and responsibilities would be worthwhile.
Collapse
Affiliation(s)
- A C Schöpf-Lazzarino
- Section of Health Care Research and Rehabilitation Research, Faculty of Medicine and Medical Centre, University of Freiburg, Hugstetter Str. 49, 79106, Freiburg, Germany
- Division of General Practice/Family Medicine, Faculty of Medicine and Medical Centre, University of Freiburg, Freiburg, Germany
| | - P Böhm
- Deutsche Rheuma-Liga Bundesverband e. V., Bonn, Germany
| | - U Garske
- Deutsche Rheuma-Liga Bundesverband e. V., Bonn, Germany
| | - M Schlöffel
- Section of Health Care Research and Rehabilitation Research, Faculty of Medicine and Medical Centre, University of Freiburg, Hugstetter Str. 49, 79106, Freiburg, Germany.
| | - A Stoye
- Institute of Rehabilitation Medicine, Interdisciplinary Centre for Health Sciences, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
| | - J Lamprecht
- Institute of Rehabilitation Medicine, Interdisciplinary Centre for Health Sciences, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
| | - W Mau
- Institute of Rehabilitation Medicine, Interdisciplinary Centre for Health Sciences, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
| | - E Farin
- Section of Health Care Research and Rehabilitation Research, Faculty of Medicine and Medical Centre, University of Freiburg, Hugstetter Str. 49, 79106, Freiburg, Germany
| |
Collapse
|